Trials / Conditions / CCND1 Positive
CCND1 Positive
3 registered clinical trials studyying CCND1 Positive.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Ibrutinib Plus Rituximab and Lenalidomide in Treating Elderly Participants With Newly Diagnosed Mantle Cell Ly NCT03232307 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Bendamustine, Obinutuzumab, and Venetoclax in Patients With Untreated Mantle Cell Lymphoma NCT03872180 | Emory University | Phase 2 |
| Active Not Recruiting | Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patient NCT01880567 | M.D. Anderson Cancer Center | Phase 2 |